Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GABAPENTIN for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 95 adverse event reports in the FDA FAERS database where GABAPENTIN was used for Psoriasis.

Most Reported Side Effects for GABAPENTIN

Side Effect Reports % Deaths Hosp.
Drug ineffective 10,914 14.6% 282 1,691
Drug hypersensitivity 6,833 9.2% 245 452
Off label use 6,729 9.0% 530 1,510
Drug ineffective for unapproved indication 5,231 7.0% 26 442
Product use in unapproved indication 4,919 6.6% 206 965
Toxicity to various agents 4,839 6.5% 3,453 1,716
Completed suicide 4,111 5.5% 4,099 1,249
Dizziness 4,107 5.5% 119 876
Somnolence 3,798 5.1% 328 1,075
Fatigue 3,791 5.1% 194 947
Pain 3,656 4.9% 248 752
Nausea 3,463 4.6% 336 1,021
Headache 2,618 3.5% 183 559
Drug abuse 2,488 3.3% 1,304 764
Feeling abnormal 2,392 3.2% 32 336

Other Indications for GABAPENTIN

Product used for unknown indication (22,833) Neuralgia (6,270) Pain (4,501) Neuropathy peripheral (4,033) Fibromyalgia (1,838) Back pain (1,457) Diabetic neuropathy (1,382) Pain in extremity (1,025) Epilepsy (748) Nerve injury (706)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

GABAPENTIN Full Profile All Psoriasis Drugs GABAPENTIN Demographics GABAPENTIN Timeline